Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lillie

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1984
Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentrationC Lillie, W Kobinger
European Journal of Pharmacology|June 19, 1981
AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heartW Kobinger, C Lillie
Journal of Cardiovascular Pharmacology|July 1, 1986
Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atriaC Lillie, W Kobinger
European Journal of Pharmacology|September 3, 1984
Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent"W Kobinger, C Lillie
Journal of Cardiovascular Pharmacology|November 1, 1983
Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulationC Lillie, W Kobinger
European Journal of Pharmacology|January 28, 1983
Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutionsC Lillie, W Kobinger
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1987
Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockersC Lillie, W Kobinger
European Heart Journal|December 1, 1987
Specific bradycardic agents--a novel pharmacological class?W Kobinger, C Lillie
European Journal of Pharmacology|November 15, 1988
Effects of alinidine on survival and infarct size in rats with coronary artery occlusionR Reichhalter, C Lillie, W Kobinger
Circulation Research|June 1, 1980
Central cardiovascular alpha-adrenoceptors. Relation to peripheral receptorsW Kobinger, C Lillie, L Pichler
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1984
Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentrationC Lillie, W Kobinger
European Journal of Pharmacology|June 19, 1981
AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heartW Kobinger, C Lillie
Journal of Cardiovascular Pharmacology|July 1, 1986
Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atriaC Lillie, W Kobinger
European Journal of Pharmacology|September 3, 1984
Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent"W Kobinger, C Lillie
Journal of Cardiovascular Pharmacology|November 1, 1983
Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulationC Lillie, W Kobinger
European Journal of Pharmacology|January 28, 1983
Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutionsC Lillie, W Kobinger
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1987
Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockersC Lillie, W Kobinger
European Heart Journal|December 1, 1987
Specific bradycardic agents--a novel pharmacological class?W Kobinger, C Lillie
European Journal of Pharmacology|November 15, 1988
Effects of alinidine on survival and infarct size in rats with coronary artery occlusionR Reichhalter, C Lillie, W Kobinger
Circulation Research|June 1, 1980
Central cardiovascular alpha-adrenoceptors. Relation to peripheral receptorsW Kobinger, C Lillie, L Pichler
Pageof 2